Vedolizumab & Inflammatory Bowel Disease (IBD)

What is the approval status of Vedolizumab for the treatment of Inflammatory Bowel Disease (IBD)?

Vedolizumab, sold as Entyvio TM, is approved in the United States and European Union for ulcerative colitis and Crohn’s disease. FDA: Treatment for adults with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease. EMA: For adults with moderately to severely active ulcerative colitis or Crohn’s disease who have not responded well, lost response, or are intolerant to conventional ther…